A TikTok trend sold out Ozempic, leaving people with diabetes dizzy, scared


For the more than 35 million people who live with type 2 diabetes, the shortages have added yet another layer to managing an already complicated and costly chronic illness. — Image by jcomp on Freepik

For more than a month, Shane Anthony, a 57-year-old auto mechanic, hasn’t been able to get his diabetes medication.

Ozempic, an injection that keeps blood sugar levels in check for patients with type 2 diabetes, has been in shortage for about four months, according to the database maintained by the US Food and Drug Administration, and is backordered at Anthony’s Seattle pharmacy. Without the Novo Nordisk A/S-made prescription, he has suffered recurring dizzy spells while repairing cars. Alternative medications are either out of stock or not covered by his insurance.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Tech News

Musk and Ryanair CEO clash over cost of Starlink Wi-Fi on planes
OpenAI to test ads in ChatGPT in bid to boost revenue
ClickHouse valued at $15 billion as database analytics firm rides AI wave
Elon Musk's X largely back up after outage affects thousands worldwide
Tesla gets 5-week extension in US probe of Full Self-Driving traffic violations
Starlink-rival Eutelsat signs deal with Europe's MaiaSpace to launch satellites
India's Tata Tech has quarterly profit plummet 96% on one-time labour code charge
India's Tech Mahindra beats quarterly revenue view on manufacturing strength
Wipro lags rivals with soft deal wins, weak fourth-quarter view
Meta begins job cuts as it shifts from metaverse to AI devices

Others Also Read